Al-Harthi SE - Search Results

1

Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals.

Osman AM, Al-Harthi SE, AlArabi OM, Elshal MF, Ramadan WS, Alaama MN, Al-Kreathy HM, Damanhouri ZA, Osman OH. Osman AM, et al. Cancer Cell Int. 2013 May 28;13:52. doi: 10.1186/1475-2867-13-52. eCollection 2013. Cancer Cell Int. 2013. PMID: 23714221 Free PMC article.

2

Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line.

Osman AM, Bayoumi HM, Al-Harthi SE, Damanhouri ZA, Elshal MF. Osman AM, et al. Cancer Cell Int. 2012 Nov 16;12(1):47. doi: 10.1186/1475-2867-12-47. Cancer Cell Int. 2012. PMID: 23153194 Free PMC article.

3

Appraisal of antimicrobial prescribing practices of governmental and non-governmental dentists for hospitals in the western region of Saudi Arabia.

Al-Harthi SE, Khan LM, Abed HH, Alkreathy HM, Ali AS. Al-Harthi SE, et al. Saudi Med J. 2013 Dec;34(12):1262-9. Saudi Med J. 2013. PMID: 24343466

4

Amelioration of doxorubicin‑induced cardiotoxicity by resveratrol.

Al-Harthi SE, Alarabi OM, Ramadan WS, Alaama MN, Al-Kreathy HM, Damanhouri ZA, Khan LM, Osman AM. Al-Harthi SE, et al. Mol Med Rep. 2014 Sep;10(3):1455-60. doi: 10.3892/mmr.2014.2384. Epub 2014 Jul 15. Mol Med Rep. 2014. PMID: 25059399

5

Modulatory role of resveratrol on cytotoxic activity of cisplatin, sensitization and modification of cisplatin resistance in colorectal cancer cells.

Osman AM, Al-Malki HS, Al-Harthi SE, El-Hanafy AA, Elashmaoui HM, Elshal MF. Osman AM, et al. Among authors: al harthi se. Mol Med Rep. 2015 Jul;12(1):1368-74. doi: 10.3892/mmr.2015.3513. Epub 2015 Mar 19. Mol Med Rep. 2015. PMID: 25815689

6

Perceptions and knowledge regarding antimicrobial stewardship among clinicians in Jeddah, Saudi Arabia.

Al-Harthi SE, Khan LM, Osman AM, Alim MA, Saadah OI, Almohammadi AA, Khan FM, Kamel FO. Al-Harthi SE, et al. Saudi Med J. 2015 Jul;36(7):813-20. doi: 10.15537/smj.2015.7.11833. Saudi Med J. 2015. PMID: 26108585 Free PMC article.

7

Detection of adverse drug reactions by medication antidote signals and comparison of their sensitivity with common methods of ADR detection.

Khan LM, Al-Harthi SE, Alkreathy HM, Osman AM, Ali AS. Khan LM, et al. Among authors: al harthi se. Saudi Pharm J. 2015 Oct;23(5):515-22. doi: 10.1016/j.jsps.2014.10.003. Epub 2014 Oct 31. Saudi Pharm J. 2015. PMID: 26594117 Free PMC article.

8

Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions.

Khan LM, Al-Harthi SE, Osman AM, Sattar MA, Ali AS. Khan LM, et al. Among authors: al harthi se. Saudi Pharm J. 2016 Jul;24(4):485-93. doi: 10.1016/j.jsps.2015.01.010. Epub 2015 Jan 10. Saudi Pharm J. 2016. PMID: 27330379 Free PMC article. Review.

9

Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance.

Al-Malky HS, Al Harthi SE, Osman AM. Al-Malky HS, et al. Among authors: al harthi se. J Oncol Pharm Pract. 2020 Mar;26(2):434-444. doi: 10.1177/1078155219877931. Epub 2019 Oct 9. J Oncol Pharm Pract. 2020. PMID: 31594518 Review.

10

The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats.

Al-Zahrani YA, Al-Harthi SE, Khan LM, El-Bassossy HM, Edris SM, A Sattar MA. Al-Zahrani YA, et al. Among authors: al harthi se. Saudi Pharm J. 2015 Oct;23(5):487-98. doi: 10.1016/j.jsps.2014.12.001. Epub 2015 Jan 7. Saudi Pharm J. 2015. PMID: 26594114 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters